Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer}, Pregnancy & Fertility Testing {Pregnancy Test

Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

The lateral flow assays market is set to expand at a robust pace by 2027 owing to burgeoning need for diagnostic testing during the COVID-19 pandemic across the globe.

Lateral flow assays (LFA) are simple paper-based devices designed to detect a target analyte's presence (or absence) in a liquid sample without the need for specialized and expensive equipment. These tests are typically used for medical diagnostics for point of care testing or home testing, or in laboratory settings. Latest technological advancements in diagnostics have driven product demand in recent years.

Notably, industry players are employing lucrative strategies to accommodate the surging demand for infectious disease testing due to the ongoing COVID-19 pandemic, strengthening the overall business outlook.

For instance, in April 2020, Abingdon Health, a leading manufacturer of high-quality rapid lateral flow tests, announced the acquisition of UK-based Concepta plc’s lateral flow manufacturing facility based in Doncaster. The deal enabled Abingdon to expand its lateral flow manufacturing presence with the integration of Concepta’s manufacturing facility, which is equipped with a fully automated lateral flow manufacturing capacity, including automated cartridge assembly, reel-to-reel spraying, and lamination.

The lateral flow assays market has been segmented on the basis of technique, product, end-use, application, and region. In terms of product, the market has further been divided into readers and kits. The readers sub-segment attained a sizable valuation of nearly USD 1.6 billion in 2020 and is expected to witness steady expansion over the assessment period.

With respect to application, the market has been categorized into drug of abuse testing, infectious disease, cholesterol testing, cardiac marker testing, pregnancy & fertility testing, and others. The drug of abuse testing sub-segment is slated to register considerable growth at a CAGR of about 6.6% through the forecast timeline.

From the technique point of view, the lateral flow assays market has been classified into multiplex detection assays, sandwich assays, and competitive assays. In 2020, the competitive assays sub-segment accounted for a market share of around 33.4% and is speculated to garner notable gains over the analysis period.

Based on end-use, the market has been segregated into homecare settings, diagnostic laboratories, hospitals & clinics, and others. The lateral flow assays industry from the homecare settings sub-segment is foreseen to reach a valuation of more than USD 3.6 billion by 2027.

From the regional spectrum, the Latin America lateral flow assays market held over 5.1% market share in 2020 and is estimated to showcase optimistic growth over 2021-2027. Meanwhile, the Middle East & Africa lateral flow assays industry is anticipated to gain significant traction at almost 5.4% CAGR over the review period.


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Lateral flow assays industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Technique trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Lateral Flow Assays Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of infectious disease
3.3.1.2 Growing demand for point-of-care testing
3.3.1.3 Technological advancements
3.3.2 Industry pitfalls & challenges
3.3.2.1 Low accuracy of results
3.3.2.2 Availability of substitute product
3.3.2.3 Stringent regulatory framework
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By technique
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Porter's analysis
3.7 Competitive landscape, 2020
3.7.1 Company matrix analysis
3.8 PESTEL analysis
Chapter 4 Lateral Flow Assays Market, By Product
4.1 Key segment trends
4.2 Kits
4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.3 Readers
4.3.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 Lateral Flow Assays Market, By Application
5.1 Key segment trends
5.2 Infectious disease testing
5.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.2.2 Influenza
5.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.2.3 Sexually transmitted disease (STD)
5.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.2.4 Hepatitis
5.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
5.2.5 Tuberculosis
5.2.5.1 Market size, by region, 2016 - 2027 (USD Million)
5.2.6 Others
5.2.6.1 Market size, by region, 2016 - 2027 (USD Million)
5.3 Cardiac marker testing
5.3.1 Creatine kinase-MB (CK-MB)
5.3.1.1 Market size, by region, 2016 - 2027 (USD Million)
5.3.2 Myoglobin
5.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.3.3 D-dimer
5.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.3.4 Others
5.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
5.4 Pregnancy and fertility testing
5.4.1 Market size, by region, 2016 - 2027 (USD Million)
5.4.2 Pregnancy testing
5.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.4.3 Fertility testing
5.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.5 Cholesterol testing
5.5.1 Market size, by region, 2016 - 2027 (USD Million)
5.6 Drug-of-Abuse (DoA) testing
5.6.1 Market size, by region, 2016 - 2027 (USD Million)
5.7 Other products
5.7.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 Lateral Flow Assays Market, By Technique
6.1 Key segment trend
6.2 Sandwich assays
6.2.1 Market size, by region, 2016 - 2027 (USD Million)
6.3 Competitive assays
6.3.1 Market size, by region, 2016 - 2027 (USD Million)
6.4 Multiplex detection assays
6.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 7 Lateral Flow Assays Market, By End-use
7.1 Key segment trend
7.2 Hospital & clinics
7.2.1 Market size, by region, 2016 - 2027 (USD Million)
7.3 Diagnostic laboratories
7.3.1 Market size, by region, 2016 - 2027 (USD Million)
7.4 Homecare settings
7.4.1 Market size, by region, 2016 - 2027 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 8 Lateral Flow Assays Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2016 - 2027 (USD Million)
8.2.2 Market size, by product, 2016 - 2027 (USD Million)
8.2.3 Market size, by application, 2016 - 2027 (USD Million)
8.2.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.2.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.2.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.2.4 Market size, by technique, 2016 - 2027 (USD Million)
8.2.5 Market size, by end-use, 2016 - 2027 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by product, 2016 - 2027 (USD Million)
8.2.6.2 Market size, by application, 2016 - 2027 (USD Million)
8.2.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.2.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.2.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.2.6.3 Market size, by technique, 2016 - 2027 (USD Million)
8.2.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by product, 2016 - 2027 (USD Million)
8.2.7.2 Market size, by application, 2016 - 2027 (USD Million)
8.2.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.2.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.2.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.2.7.3 Market size, by technique, 2016 - 2027 (USD Million)
8.2.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2016 - 2027 (USD Million)
8.3.2 Market size, by product, 2016 - 2027 (USD Million)
8.3.3 Market size, by application, 2016 - 2027 (USD Million)
8.3.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.4 Market size, by technique, 2016 - 2027 (USD Million)
8.3.5 Market size, by end-use, 2016 - 2027 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
8.3.6.2 Market size, by application, 2016 - 2027 (USD Million)
8.3.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.6.3 Market size, by technique, 2016 - 2027 (USD Million)
8.3.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.3.7 UK
8.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
8.3.7.2 Market size, by application, 2016 - 2027 (USD Million)
8.3.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.7.3 Market size, by technique, 2016 - 2027 (USD Million)
8.3.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.3.8 France
8.3.8.1 Market size, by product, 2016 - 2027 (USD Million)
8.3.8.2 Market size, by application, 2016 - 2027 (USD Million)
8.3.8.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.8.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.8.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.8.3 Market size, by technique, 2016 - 2027 (USD Million)
8.3.8.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by product, 2016 - 2027 (USD Million)
8.3.9.2 Market size, by application, 2016 - 2027 (USD Million)
8.3.9.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.9.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.9.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.9.3 Market size, by technique, 2016 - 2027 (USD Million)
8.3.9.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.3.10 Italy
8.3.10.1 Market size, by product, 2016 - 2027 (USD Million)
8.3.10.2 Market size, by application, 2016 - 2027 (USD Million)
8.3.10.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.3.10.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.3.10.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.3.10.3 Market size, by technique, 2016 - 2027 (USD Million)
8.3.10.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2016 - 2027 (USD Million)
8.4.2 Market size, by product, 2016 - 2027 (USD Million)
8.4.3 Market size, by application, 2016 - 2027 (USD Million)
8.4.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.4.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.4.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.4.4 Market size, by technique, 2016 - 2027 (USD Million)
8.4.5 Market size, by end-use, 2016 - 2027 (USD Million)
8.4.6 China
8.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
8.4.6.2 Market size, by application, 2016 - 2027 (USD Million)
8.4.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.4.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.4.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.4.6.3 Market size, by technique, 2016 - 2027 (USD Million)
8.4.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.4.7 Japan
8.4.7.1 Market size, by product, 2016 - 2027 (USD Million)
8.4.7.2 Market size, by application, 2016 - 2027 (USD Million)
8.4.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.4.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.4.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.4.7.3 Market size, by technique, 2016 - 2027 (USD Million)
8.4.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.4.8 India
8.4.8.1 Market size, by product, 2016 - 2027 (USD Million)
8.4.8.2 Market size, by application, 2016 - 2027 (USD Million)
8.4.8.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.4.8.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.4.8.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.4.8.3 Market size, by technique, 2016 - 2027 (USD Million)
8.4.8.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by product, 2016 - 2027 (USD Million)
8.4.9.2 Market size, by application, 2016 - 2027 (USD Million)
8.4.9.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.4.9.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.4.9.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.4.9.3 Market size, by technique, 2016 - 2027 (USD Million)
8.4.9.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2016 - 2027 (USD Million)
8.5.2 Market size, by product, 2016 - 2027 (USD Million)
8.5.3 Market size, by application, 2016 - 2027 (USD Million)
8.5.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.5.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.5.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.5.4 Market size, by technique, 2016 - 2027 (USD Million)
8.5.5 Market size, by end-use, 2016 - 2027 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by product, 2016 - 2027 (USD Million)
8.5.6.2 Market size, by application, 2016 - 2027 (USD Million)
8.5.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.5.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.5.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.5.6.3 Market size, by technique, 2016 - 2027 (USD Million)
8.5.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by product, 2016 - 2027 (USD Million)
8.5.7.2 Market size, by application, 2016 - 2027 (USD Million)
8.5.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.5.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.5.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.5.7.3 Market size, by technique, 2016 - 2027 (USD Million)
8.5.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.6 Middle East and Africa
8.6.1 Market size, by country, 2016 - 2027 (USD Million)
8.6.2 Market size, by product, 2016 - 2027 (USD Million)
8.6.3 Market size, by application, 2016 - 2027 (USD Million)
8.6.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.6.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.6.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.6.4 Market size, by technique, 2016 - 2027 (USD Million)
8.6.5 Market size, by end-use, 2016 - 2027 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by product, 2016 - 2027 (USD Million)
8.6.6.2 Market size, by application, 2016 - 2027 (USD Million)
8.6.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.6.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.6.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.6.6.3 Market size, by technique, 2016 - 2027 (USD Million)
8.6.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
8.6.7 Saudi Arabia
8.6.7.1 Market size, by product, 2016 - 2027 (USD Million)
8.6.7.2 Market size, by application, 2016 - 2027 (USD Million)
8.6.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
8.6.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
8.6.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
8.6.7.3 Market size, by technique, 2016 - 2027 (USD Million)
8.6.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
Chapter 9 Company Profiles
9.1 Competitive dashboard
9.2 Abingdon Health
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Abbott
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Bio-Rad Laboratories
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Bioeasy Biotechnology Inc
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 BioMerieux.
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Hologic’s Inc
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 F. Hoffmann La Roche
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Thermo Fischer Scientific
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 OPERON
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Quidel Corporation
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
Data Tables
TABLE 1 Global lateral flow assays market, 2016 - 2020 (USD Million)
TABLE 2 Global lateral flow assays market, 2021 - 2027 (USD Million)
TABLE 3 Global lateral flow assays market, by product, 2016 - 2020 (USD Million)
TABLE 4 Global lateral flow assays market, by product, 2021 - 2027 (USD Million)
TABLE 5 Global lateral flow assays market, by application, 2016 - 2020 (USD Million)
TABLE 6 Global lateral flow assays market, by application, 2021 - 2027 (USD Million)
TABLE 7 Global lateral flow assays market, by technique, 2016 - 2020 (USD Million)
TABLE 8 Global lateral flow assays market, by technique, 2021 - 2027 (USD Million)
TABLE 9 Global lateral flow assays market, by end-use, 2016 - 2020 (USD Million)
TABLE 10 Global lateral flow assays market, by end-use, 2021 - 2027 (USD Million)
TABLE 11 Global lateral flow assays market, by region, 2016 - 2020 (USD Million)
TABLE 12 Global lateral flow assays market, by region, 2021 - 2027 (USD Million)
TABLE 13 Industry impact forces
TABLE 14 Kits market size, by region, 2016 - 2020 (USD Million)
TABLE 15 Kits market size, by region, 2021 - 2027 (USD Million)
TABLE 16 Reader market size, by region, 2016 - 2020 (USD Million)
TABLE 17 Reader market size, by region, 2021 - 2027 (USD Million)
TABLE 18 Infectious disease testing market size, by region, 2016 - 2020 (USD Million)
TABLE 19 Infectious disease testing market size, by region, 2021 - 2027 (USD Million)
TABLE 20 Influenza market size, by region, 2016 - 2020 (USD Million)
TABLE 21 Influenza market size, by region, 2021 - 2027 (USD Million)
TABLE 22 STDs market size, by region, 2016 - 2020 (USD Million)
TABLE 23 STDs market size, by region, 2021 - 2027 (USD Million)
TABLE 24 Hepatitis market size, by region, 2016 - 2020 (USD Million)
TABLE 25 Hepatitis market size, by region, 2021 - 2027 (USD Million)
TABLE 26 Tuberculosis market size, by region, 2016 - 2020 (USD Million)
TABLE 27 Tuberculosis market size, by region, 2021 - 2027 (USD Million)
TABLE 28 Other market size, by region, 2016 - 2020 (USD Million)
TABLE 29 Other market size, by region, 2021 - 2027 (USD Million)
TABLE 30 Cardiac marker testing market size, by region, 2016 - 2020 (USD Million)
TABLE 31 Cardiac marker testing market size, by region, 2021 - 2027 (USD Million)
TABLE 32 CK-MB market size, by region, 2016 - 2020 (USD Million)
TABLE 33 CK-MB market size, by region, 2021 - 2027 (USD Million)
TABLE 34 Myoglobin market size, by region, 2016 - 2020 (USD Million)
TABLE 35 Myoglobin market size, by region, 2021 - 2027 (USD Million)
TABLE 36 D-dimer market size, by region, 2016 - 2020 (USD Million)
TABLE 37 D-dimer market size, by region, 2021 - 2027 (USD Million)
TABLE 38 Others market size, by region, 2016 - 2020 (USD Million)
TABLE 39 Others market size, by region, 2021 - 2027 (USD Million)
TABLE 40 Pregnancy and fertility testing size, by region, 2016 - 2020 (USD Million)
TABLE 41 Pregnancy and fertility testing market size, by region, 2021 - 2027 (USD Million)
TABLE 42 Pregnancy testing market size, by region, 2016 - 2020 (USD Million)
TABLE 43 Pregnancy testing market size, by region, 2021 - 2027 (USD Million)
TABLE 44 Fertility testing market size, by region, 2016 - 2020 (USD Million)
TABLE 45 Fertility testing market size, by region, 2021 - 2027 (USD Million)
TABLE 46 Cholesterol testing market size, by region, 2016 - 2020 (USD Million)
TABLE 47 Cholesterol testing market size, by region, 2021 - 2027 (USD Million)
TABLE 48 Drug-of-Abuse testing market size, by region, 2016 - 2020 (USD Million)
TABLE 49 Drug-of-Abuse testing market size, by region, 2021 - 2027 (USD Million)
TABLE 50 Other products market size, by region, 2016 - 2020 (USD Million)
TABLE 51 Other products market size, by region, 2021 - 2027 (USD Million)
TABLE 52 Sandwich assays market size, by region, 2016 - 2020 (USD Million)
TABLE 53 Sandwich assays market size, by region, 2021 - 2027 (USD Million)
TABLE 54 Competitive assays market size, by region, 2016 - 2020 (USD Million)
TABLE 55 Competitive assays market size, by region, 2021 - 2027 (USD Million)
TABLE 56 Multiplex detection assays market size, by region, 2016 - 2020 (USD Million)
TABLE 57 Multiplex detection assays market size, by region, 2021 - 2027 (USD Million)
TABLE 58 Hospital & clinics market size, by region, 2016 - 2020 (USD Million)
TABLE 59 Hospital & clinics market size, by region, 2021 - 2027 (USD Million)
TABLE 60 Diagnostic laboratories market size, by region, 2016 - 2020 (USD Million)
TABLE 61 Diagnostic laboratories market size, by region, 2021 - 2027 (USD Million)
TABLE 62 Homecare settings market size, by region, 2016 - 2020 (USD Million)
TABLE 63 Homecare settings market size, by region, 2021 - 2027 (USD Million)
TABLE 64 Others market size, by region, 2016 - 2020 (USD Million)
TABLE 65 Others market size, by region, 2021 - 2027 (USD Million)
TABLE 66 North America lateral flow assays market size, by country, 2016 - 2020 (USD Million)
TABLE 67 North America lateral flow assays market size, by country, 2021 - 2027 (USD Million)
TABLE 68 North America lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 69 North America lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 70 North America lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 71 North America lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 72 North America lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 73 North America lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 74 North America lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 75 North America lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 76 North America lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 77 North America lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 78 North America lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 79 North America lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 80 North America lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 81 North America lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 82 U.S. lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 83 U.S. lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 84 U.S. lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 85 U.S. lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 86 U.S. lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 87 U.S. lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 88 U.S. lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 89 U.S. lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 90 U.S. lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 91 U.S. lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 92 U.S. lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 93 U.S. lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 94 U.S. lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 95 U.S. lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 96 Canada lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 97 Canada lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 98 Canada lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 99 Canada lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 100 Canada lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 101 Canada lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 102 Canada lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 103 Canada lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 104 Canada lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 105 Canada lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 106 Canada lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 107 Canada lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 108 Canada lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 109 Canada lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 110 Europe lateral flow assays market size, by country, 2016 - 2020 (USD Million)
TABLE 111 Europe lateral flow assays market size, by country, 2021 - 2027 (USD Million)
TABLE 112 Europe lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 113 Europe lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 114 Europe lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 115 Europe lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 116 Europe lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 117 Europe lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 118 Europe lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 119 Europe lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 120 Europe lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 121 Europe lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 122 Europe lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 123 Europe lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 124 Europe lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 125 Europe lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 126 Germany lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 127 Germany lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 128 Germany lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 129 Germany lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 130 Germany lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 131 Germany lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 132 Germany lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 133 Germany lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 134 Germany lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 135 Germany lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 136 Germany lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 137 Germany lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 138 Germany lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 139 Germany lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 140 UK lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 141 UK lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 142 UK lateral flow assays market size, by application, 2016 - 2020 (USD Million)
TABLE 143 UK lateral flow assays market size, by application, 2021 - 2027 (USD Million)
TABLE 144 UK lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
TABLE 145 UK lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
TABLE 146 UK lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
TABLE 147 UK lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
TABLE 148 UK lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
TABLE 149 UK lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
TABLE 150 UK lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
TABLE 151 UK lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
TABLE 152 UK lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
TABLE 153 UK lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
TABLE 154 France lateral flow assays market size, by product, 2016 - 2020 (USD Million)
TABLE 155 France lateral flow assays market size, by product, 2021 - 2027 (USD Million)
TABLE 156 France lateral flow assays market size, by application, 2016 -

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings